162 related articles for article (PubMed ID: 37974462)
1. Multi-omics integration analysis unveils heterogeneity in breast cancer at the individual level.
Zhao Z; Jin T; Chen B; Dong Q; Liu M; Guo J; Song X; Li Y; Chen T; Han H; Liang H; Gu Y
Cell Cycle; 2023 Oct; 22(20):2229-2244. PubMed ID: 37974462
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: a large data-based multi-omics study.
Yuan Q; Lu X; Guo H; Sun J; Yang M; Liu Q; Tong M
J Transl Med; 2023 Nov; 21(1):871. PubMed ID: 38037058
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures.
Li J; Wu J; Han J
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672784
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer onco-signatures reveal a novel mitochondrial subtype of luminal breast cancer with specific regulators.
Simeone I; Ceccarelli M
J Transl Med; 2023 Jan; 21(1):55. PubMed ID: 36717859
[TBL] [Abstract][Full Text] [Related]
5. Classifying breast cancer subtypes on multi-omics data via sparse canonical correlation analysis and deep learning.
Huang Y; Zeng P; Zhong C
BMC Bioinformatics; 2024 Mar; 25(1):132. PubMed ID: 38539064
[TBL] [Abstract][Full Text] [Related]
6. MOBCdb: a comprehensive database integrating multi-omics data on breast cancer for precision medicine.
Xie B; Yuan Z; Yang Y; Sun Z; Zhou S; Fang X
Breast Cancer Res Treat; 2018 Jun; 169(3):625-632. PubMed ID: 29429018
[TBL] [Abstract][Full Text] [Related]
7. Integrative multi-omic sequencing reveals the MMTV-Myc mouse model mimics human breast cancer heterogeneity.
Broeker CD; Ortiz MMO; Murillo MS; Andrechek ER
Breast Cancer Res; 2023 Oct; 25(1):120. PubMed ID: 37805590
[TBL] [Abstract][Full Text] [Related]
8. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
Kim D; Li R; Dudek SM; Ritchie MD
J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
[TBL] [Abstract][Full Text] [Related]
9. Molecular Characterization and Landscape of Breast cancer Models from a multi-omics Perspective.
Ortiz MMO; Andrechek ER
J Mammary Gland Biol Neoplasia; 2023 Jun; 28(1):12. PubMed ID: 37269418
[TBL] [Abstract][Full Text] [Related]
10. Cancer Target Gene Screening: a web application for breast cancer target gene screening using multi-omics data analysis.
Kim HY; Choi HJ; Lee JY; Kong G
Brief Bioinform; 2020 Mar; 21(2):663-675. PubMed ID: 30698638
[TBL] [Abstract][Full Text] [Related]
11. BRCA-Pathway: a structural integration and visualization system of TCGA breast cancer data on KEGG pathways.
Kim I; Choi S; Kim S
BMC Bioinformatics; 2018 Feb; 19(Suppl 1):42. PubMed ID: 29504910
[TBL] [Abstract][Full Text] [Related]
12. Integration of multi-omics data reveals a novel hybrid breast cancer subtype and its biomarkers.
Wang ZZ; Li XH; Wen XL; Wang N; Guo Y; Zhu X; Fu SH; Xiong FF; Bai J; Gao XL; Wang HJ
Front Oncol; 2023; 13():1130092. PubMed ID: 37064087
[TBL] [Abstract][Full Text] [Related]
13. An Integrated Multi-Omics Analysis Identifying Immune Subtypes of Pancreatic Cancer.
Su Y; Wang F; Lei Z; Li J; Ma M; Yan Y; Zhang W; Chen X; Xu B; Hu T
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203311
[TBL] [Abstract][Full Text] [Related]
14. Subtype-DCC: decoupled contrastive clustering method for cancer subtype identification based on multi-omics data.
Zhao J; Zhao B; Song X; Lyu C; Chen W; Xiong Y; Wei DQ
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36702755
[TBL] [Abstract][Full Text] [Related]
15. A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscape.
Xie P; An R; Yu S; He J; Zhang H
J Transl Med; 2021 Sep; 19(1):398. PubMed ID: 34544424
[TBL] [Abstract][Full Text] [Related]
16. Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
Zhu B; Tse LA; Wang D; Koka H; Zhang T; Abubakar M; Lee P; Wang F; Wu C; Tsang KH; Chan WC; Law SH; Li M; Li W; Wu S; Liu Z; Huang B; Zhang H; Tang E; Kan Z; Lee S; Park YH; Nam SJ; Wang M; Sun X; Jones K; Zhu B; Hutchinson A; Hicks B; Prokunina-Olsson L; Shi J; Garcia-Closas M; Chanock S; Yang XR
Breast Cancer Res; 2019 Dec; 21(1):147. PubMed ID: 31856876
[TBL] [Abstract][Full Text] [Related]
17. moBRCA-net: a breast cancer subtype classification framework based on multi-omics attention neural networks.
Choi JM; Chae H
BMC Bioinformatics; 2023 Apr; 24(1):169. PubMed ID: 37101124
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of the Tumor Microenvironment Across Molecular Subtypes of Breast Cancer.
Kashyap D; Bal A; Irinike S; Khare S; Bhattacharya S; Das A; Singh G
Appl Immunohistochem Mol Morphol; 2023 Sep; 31(8):533-543. PubMed ID: 37358863
[TBL] [Abstract][Full Text] [Related]
19. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
Front Immunol; 2021; 12():723172. PubMed ID: 34539658
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of Tumor Microenvironment in Luminal B-Type Breast Cancer.
Lv J; Ren J; Zheng J; Zhang F; Han M
Dis Markers; 2022; 2022():5621441. PubMed ID: 35242245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
